Login to Your Account

Glybera Gains Official EMA Nod as First Gene Therapy

By Nuala Moran
Staff Writer

Friday, November 2, 2012
Glybera formally became the first gene therapy to be approved in a regulated market, as the European Commission gave the rubber stamp to the treatment for the ultra-rare inherited disorder lipoprotein lipase deficiency.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription